On the other hand, a recent randomized controlled trial of Japanese patients with asymptomatic hyperuricemia reported that 24-month treatment with another XOR inhibitor, febuxostat, did not delay carotid atherosclerosis progression (10). This evidence concerns the gene XDH and hyperuricemia.